Molly Shea on Muck Rack

Molly Shea

  • Psychotherapist, Refresh Psychotherapy NYC
New York
As seen in: Yahoo Life, Fox News, New York Post, News.com.au, Fast Company, MarketWatch, Bustle, Glamour, Yahoo, Elite Daily and
Freelance writer.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Molly

Contact Molly, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

10.31.25 -- Bringing CGT Home: Equipping Community Hospitals For The Next Frontier

|
By Robin Johnson, Molly Shea, inSeption Group, Ben Edwards
| Cell & Gene
Join Jon O'Connell and experts on this Cell & Gene Live event, exploring whether minimum viability can help gene therapy developers make smarter sourcing decisions — from research-grade production through clinical and commercial phases, where cost and quality can make or break a product. Registration is free with support from Roche CustomBiotech.
Open in Who Shared Issue with article?

Writing Effective Clinical Regulatory Documents For Gene Therapy Trials

|
By Robin Johnson, Molly Shea, inSeption Group
| Pharmaceutical Online
By Robin Johnson and Molly Shea, inSeption Group While each gene therapy program presents unique opportunities and obstacles, the challenges of writing clinical regulatory documents for gene therapy programs can generally be categorized into three key areas: clinical trial design, safety reporting, and template requirements for Biologics License Applications (BLAs) and Marketing Authorization Applications (MAAs).
Open in Who Shared Issue with article?

Writing Effective Clinical Regulatory Documents For Gene Therapy Trials

|
By Robin Johnson, Molly Shea, inSeption Group, Louis Garguilo 
| Outsourced Pharma
By Robin Johnson and Molly Shea, inSeption Group While each gene therapy program presents unique opportunities and obstacles, the challenges of writing clinical regulatory documents for gene therapy programs can generally be categorized into three key areas: clinical trial design, safety reporting, and template requirements for Biologics License Applications (BLAs) and Marketing Authorization Applications (MAAs).
Open in Who Shared Issue with article?
See all 952 licensed articles (958 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Molly

Contact Molly, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified